Skip to main content
Clinical Trials/CTRI/2020/06/025812
CTRI/2020/06/025812
Not yet recruiting
未知

Association between early echocardiographic parameters of hemodynamic significance and plasma NT pro-BNP and a composite outcome of death or postnatal morbidities by 36 weeks postmenstrual age in preterm neonates of 25-29 weeks gestation with echocardiographic evidence of patent ductus arteriosus: a prospective cohort study

none0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I00-I99- Diseases of the circulatory system
Sponsor
none
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • Neonates born in the unit between 25 to 29 weeks and 6 days will be eligible for inclusion

Exclusion Criteria

  • 1\. Antenatally suspected or proven congenital heart disease
  • 2\. Suspected congenital heart disease (other than PDA) on the first screening postnatal
  • echocardiography (would be however
  • included if proven as normal by a Pediatric
  • cardiologist before the echo done on
  • 3\. Major or life threatening congenital
  • malformation
  • 4\. Suspected congenital rubella infection based on the maternal positive serology for IgM
  • rubella antibodies anytime during the
  • current pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials